Sayenko Kharenko’s antitrust team has provided legal assistance in merger clearance with the Antimonopoly Committee of Ukraine (the "AMC") for the EUR 165 million acquisition of Ivonton Holdings Limited ("Ivonton") by Valeant Pharmaceuticals International, Inc. ("Valeant"), a holding company of the Valeant group of companies.
The acquisition will enable Valeant to increase its presence on Russian market of pharmaceuticals.
Ivonton is a holding company of Natur Produkt group, a leader on Russian market of pharmaceuticals.
Valeant is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.
After the review of the proposed transaction, the AMC concluded that its implementation neither poses threats to competition nor significantly limits competition on any product market in Ukraine.
Sayenko Kharenko's competition team for the current transaction included counsel Dmitry Taranyk and associates Maksym Nazarenko and Yulia Kuyda, and was led by partner Vladimir Sayenko.